A Clinical-Radiomics Nomogram for Functional Outcome Predictions in Ischemic Stroke.

Introduction: Stroke remains a leading cause of death and disability worldwide. Effective and prompt prognostic evaluation is vital for determining the appropriate management strategy. Radiomics is an emerging noninvasive method used to identify the quantitative imaging indicators for predicting important clinical outcomes. This study was conducted to investigate and validate a radiomics nomogram for predicting ischemic stroke prognosis using the modified Rankin scale (mRS).

Methods: A total of 598 consecutive patients with subacute infarction confirmed by diffusion-weighted imaging (DWI), from January 2018 to December 2019, were retrospectively assessed. They were assigned to the good (mRS ≤ 2) and poor (mRS > 2) functional outcome groups, respectively. Then, 399 patients examined by MR scanner 1 and 199 patients scanned by MR scanner 2 were assigned to the training and validation cohorts, respectively. Infarction lesions underwent manual segmentation on DWI, extracting 402 radiomic features. A radiomics nomogram encompassing patient characteristics and the radiomics signature was built using a multivariate logistic regression model. The performance of the nomogram was evaluated in the training and validation cohorts. Ultimately, decision curve analysis was implemented to assess the clinical value of the nomogram. The performance of infarction lesion volume was also evaluated using univariate analysis.

Results: Stroke lesion volume showed moderate performance, with an area under the curve (AUC) of 0.678. The radiomics signature, including 11 radiomics features, exhibited good prediction performance. The radiomics nomogram, encompassing clinical characteristics (age, hemorrhage, and 24 h National Institutes of Health Stroke Scale score) and the radiomics signature, presented good discriminatory potential in the training cohort [AUC = 0.80; 95% confidence interval (CI) 0.75-0.86], which was validated in the validation cohort (AUC = 0.73; 95% CI 0.63-0.82). In addition, it demonstrated good calibration in the training (p = 0.55) and validation (p = 0.21) cohorts. Decision curve analysis confirmed the clinical value of this nomogram.

Conclusion: This novel noninvasive clinical-radiomics nomogram shows good performance in predicting ischemic stroke prognosis.